CEPI Call for Proposals: Achieving an Unprecedented Acceleration of Vaccine Development and Global Manufacturing Capacity to Prevent COVID-19

CEPI Call for Proposals: Achieving an Unprecedented Acceleration of Vaccine Development and Global Manufacturing Capacity to Prevent COVID-19

Deadline: 30 June 2020

CEPI has opened an additional funding opportunity for the rapid development of vaccines against COVID-19.

(Ad) Are You Searching for Latest Grants, New Donors, Sample Proposals, Jobs and How to Apply Resources? fundsforNGOs Premium has all these and more at one place! Learn more.

The ongoing COVID-19 pandemic is a public health crisis causing unprecedented disruption to human activity. As national and regional governments assess containment measures, it is thought that only widely available safe and effective vaccines in conjunction with other public health measures will allow a return to normal life and help prevent further sickness and deaths.

CEPI is striving to accelerate vaccine development and to ensure that associated manufacturing capabilities and capacities will meet global demand as quickly as possible. This Call for Proposals will support the rapid development of vaccines striving for licensure/emergency authorization in 12-18 months or less and, to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021.

(Ad) Stop getting irritated with excessing advertisements. View the information you want quickly on a clean, ad-free and exclusive Member Dashboard that offers tools to search for grants, view latest grant opportunities, upcoming deadlines, sample proposals, downloadable ebooks and also organize your favourites! Learn more.

Objectives and the Scope of this Call

The objective of this Call for Proposals is to support the rapid development of vaccines with a goal of achieving licensure/emergency authorization in 12-18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021.

(Ad) Are you still finding it difficult to search for donors online? Join Premium and use our powerful Donor Search mechanism to find relevant donors based on your country and location or keyword. Our specially developed algorithm will search across the internet for the most relevant and useful donors of your interest willing to fund your work. Learn more.

CEPI’s core goal in releasing this call for proposals is to accelerate the development of safe and effective vaccines by organizations who can rapidly deliver at scale and to ensure that the supply of vaccine doses is made available to meet the public health need on a worldwide basis during the pandemic.

Eligibility Criteria

(Ad) Not able to keep track of so may different grant opportunities and their deadlines? No problem! fundsforNGOs Premium has a handy tool called « Deadline Calendar. » This tool will help you keep track of all upcoming grant opportunities and their deadlines and view them in a beautiful calendar format. Learn more.

The funding opportunity through this rolling Call is open worldwide, to all types of organization: forprofit companies; non-profit organisations; international institutions and foundations; joint R&D ventures; government research organisations; and other vaccine developers.
Applicants must be independent legal entities, or consortia comprised of legal entities. The main applicant, or for a consortium at least one of the members, must have experience in human vaccine development and have a track record of bringing vaccine candidates through development, ideally including licensure and manufacturing.
The applicant should either be a manufacturer or have a manufacturer with a track record of vaccine production identified within the consortium.
They encourage all Multi-National Companies (MNCs), companies in the Developing Countries Vaccine Manufacturers Network (DCVMN), and other vaccine / biologic developers with the capacity or potential to manufacture at scale to apply.
To be eligible to submit a proposal the applicant should meet the following requirements:

Have rights to a vaccine technology that has already been proven, or soon will be:
Licensed product based on the same technology or
Relevant clinical trial data based on the same technology or
If funded, preliminary clinical data from a COVID-19 vaccine candidate by the 4Q’2020.
Well characterized vaccine delivery system
Feasibility of large-scale manufacturing.
Apply for one lead COVID-19 vaccine candidate
Propose a full development plan, or one or more of the following component(s) as part of a development plan depending on the application scope:
Plans and costs to conduct clinical trials. From the application it should be clear how these trials contribute to the overall Clinical Development Plan (CDP) that constitutes pivotal trials for licensure and / or supports the expansion of the desired product label for multiple geographical regions, for example.
Parallel plans and costs to generate GMP grade materials and comparability for clinical studies
Scale-up and/or scale-out plans, including costs and timelines to generate final manufacturing scale material presented in suitable containers
Plans that support the ideal storage requirements for final product.
Plans to specifically accelerate the pathway to licensure and market readiness
Be an organization that has its own large-scale manufacturing capabilities and a mature supply chain, or is able to expand upon its existing infrastructure/footprint, or has a proven track record of transferring its vaccine technology to a global network of manufacturer(s).
Be in a position for market readiness within the next 12-18 months or less.
For more information, visit https://cepi.net/get_involved/cfps/

Partagez et envoyez cette annonce à vos amis !